Prof Yong is a member of the NCRI Myeloma Clinical Studies Group, and is chief investigator on several NCRN phase 2 studies addressing novel treatment regimens and strategies in multiple …

Kwee Yong. Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma . …

Members of the Multiple Myeloma Lab, led by Professor Kwee Yong. Prof Kwee Yong was educated at Oxford University and University College London (UCL). She completed doctoral …

University Hospital of the Vaud (Lausanne) and University of Lausanne. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in …

Jun 1, 2011 · View the University College London profile of Kwee Yong. Including their publications.

Professor Kwee Lan Yong is a specialist in haematological oncology and is renowned for her work in treating patients with multiple myeloma. She completed her medical training at Oxford …

Kwee YONG | Cited by 8,754 | of University College London, London (UCL) | Read 336 publications | Contact Kwee YONG

We investigated patient characteristics, treatment durations and outcomes, and symptom burden across the treatment pathway in Belgium, France, Germany, Italy, Spain, Switzerland and the …

Kwee Yong, PhD, FRCP, FRCPath, completed her MA at Oxford University, Oxford, UK, and MBBS and PhD at University College London (UCL), London, UK. Prof. Yong has been a …

Prof. Kwee Lan Yong is a specialist in haematological oncology and one of the leading experts in the treatment of patients with multiple myeloma. She completed her medical training at Oxford …